EUVIMEDEUVIMED entdecken
Übersichtsarbeit

CD30 ‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre

Friyana K Bhabha iD, Christopher McCormack, Belinda A Campbell, Stephen Lade, Odette Buelens, Carrie Van Der Weyden, H Miles Prince

Australasian Journal of Dermatology · 2023

DOI: 10.1111/ajd.14016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Australasian Journal of Dermatology, 2023. Verfasst von Friyana K Bhabha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Lymphomatoid Papulosis, Lymphoproliferative Disorders, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The CD30‐postive lymphoproliferative disorders, including lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma, account for up to 30% of all cutaneous T‐cell lymphomas (CTCLs) and are the second most common form of CTCLs after mycosis fungoides. Both conditions differ in their clinical presentations; however, they share the expression of the CD30 antigen as a common immunophenotypic hallmark. There is a wide spectrum of management options depending on factors such as extent of disease, staging and treatment tolerability. This Clinical Practice Statement is reflective of the current clinical practice in Australia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphomatoid PapulosisLymphoproliferative DisordersSkin NeoplasmsHumansAustraliaKi-1 Antigen

Stichwörter der Autor:innen

CD30 lymphoproliferative disorderscutaneous T cell lymphomalymphomatoid papulosisprimary cutaneous anaplastic large cell lymphoma

Substanzen

Ki-1 Antigen

Autor:innen und Institutionen

  • Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.
  • Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Nurse Practitioner, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

ORCID-Profile: Friyana K Bhabha

Zitieren

APA

Bhabha, F. K., McCormack, C., Campbell, B. A., Lade, S., Buelens, O., Van Der Weyden, C., & Prince, H. M. (2023). CD30 ‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14016

Vancouver

Bhabha FK, McCormack C, Campbell BA, Lade S, Buelens O, Van Der Weyden C, et al. CD30 ‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre. Australasian Journal of Dermatology. 2023. doi:10.1111/ajd.14016

BibTeX
@article{Bhabha2023,
  author = {Bhabha, Friyana K and McCormack, Christopher and Campbell, Belinda A and Lade, Stephen and Buelens, Odette and Van Der Weyden, Carrie and Prince, H Miles},
  title = {CD30 ‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre},
  journal = {Australasian Journal of Dermatology},
  year = {2023},
  doi = {10.1111/ajd.14016}
}
Kostenlos starten →